It is useful to think of the relationship between drug companies and society’s current and potential patients as a social contract — an understanding created for the mutual benefit of both groups that entails certain rights and duties on the part of each group.
In an interview with the Washington Post, Donald Trump vowed to force drug companies to negotiate directly with the government on prices in Medicare and Medicaid.
On Nov. 9, pharmaceutical stocks soared as Donald Trump’s election victory eased concerns about government intervention in drug pricing.
Just days before President Obama endorsed Hillary Clinton for president, the Clinton campaign announced her support for a controversial Obama administration proposal that could dramatically change seniors’ ability to obtain lifesaving drugs. The Centers for Medicare and Medicaid Services (CMS) recently proposed to experiment with the payment model for Medicare Part B that covers […]
Information never stops. We help you start your day by making sense of it all. Over 150,000 government and industry executives rely on Morning Consult to stay informed. Our original reporting and morning email briefings make it possible for you to know everything you need to know, every day, at the intersection of Wall Street and business strategy, policy and politics.